Relations (1)

related 2.00 — strongly supporting 3 facts

Psilocybin is used as an experimental model to induce schizophrenia-like symptoms, as documented in research studies [1] and [2], and is categorized alongside other substances like ketamine as a model for studying psychosis [3].

Facts (3)

Sources
Neuroimaging in psychedelic drug development: past, present, and ... nature.com Nature 1 fact
referenceF.X. Vollenweider, M.F.I. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell published 'Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action' in NeuroReport in 1998.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org Frontiers in Psychiatry 1 fact
claimKetamine and psilocybin have both been used as experimental models of psychosis.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua David B Yaden, Matthew W Johnson, Roland R Griffiths, Manoj K Doss, Albert Garcia-Romeu, Sandeep Nayak, Natalie Gukasyan, Brian N Mathur, Frederick S Barrett · Oxford University Press 1 fact
referenceVollenweider et al. published 'Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis' in Neuropsychopharmacology, which utilizes PET and FDG to study the psilocybin model of psychosis.